No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
FDA Approves Samsung Bioepis’ Unbranded Adalimumab Biosimilar
On 23 June 2025, the FDA approved Samsung Bioepis’ sBLA for an unbranded version of Hadlima® (adalimumab-bwwd), biosimilar to AbbVie’s Humira®…